BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
SIRT1
,
Angiogenesis
,
Arthritis
,
Retina
,
Pharmacogenetics
,
Fenofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
P13K
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Natural killer cell of peripheral blood
Thymus gland
T Lymphocyte (CD4+) of peripheral blood
T Lymphocyte (regulatory) of peripheral blood
T Lymphocyte (CD8+) of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Viral enteritis
Shock
Disease due to Neisseria
Systemic inflammatory response syndrome
Sepsis due to Streptococcus agalactiae
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Havrix
Metiamide
fragment C, human serum albumin
gp50 protein, Schistosoma
p40 egg antigen, Schistosoma
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
FNIP1
TBC1D23
SMARCC1
CLNS1A
HSA251708
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
OMIM - Immunodeficiencies and Related Disorders
OMIM - Immunodeficiency disorder
Clear cell carcinoma of kidney 786-O cells with EPAS1 KO or treated with HIF2A antagonist PT2385
Anti-GBM antibody effect on kidney
Analysis of peritoneal mesotheliomas following chemical treatment in F344 rats
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for P13K
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
p-AKT Expression on Clinical Outcomes in Malignant Lymphoma
A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, F…
Everolimus in Treating Patients With Recurrent Low-Grade Glioma
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and …
A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ